CIC
TMO icon

Chilton Investment Company’s Thermo Fisher Scientific TMO Stock Holding History

Chilton Investment Company’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.6M Sell
45,954
-2,170
-5% -$1.18M 0.53% 36
2025
Q4 		$27.9M Sell
48,124
-2,320
-5% -$1.31M 0.58% 32
2025
Q3 		$24.5M Sell
50,444
-3,173
-6% -$1.48M 0.5% 33
2025
Q2 		$21.7M Buy
53,617
+5,650
+12% +$2.36M 0.48% 30
2025
Q1 		$23.9M Sell
47,967
-94
-0.2% -$50.9K 0.58% 28
2024
Q4 		$25M Buy
48,061
+3,548
+8% +$1.95M 0.64% 33
2024
Q3 		$27.5M Buy
44,513
+140
+0.3% +$82.9K 0.72% 28
2024
Q2 		$24.5M Sell
44,373
-683
-2% -$391K 0.69% 30
2024
Q1 		$26.2M Sell
45,056
-42,688
-49% -$24M 0.72% 25
2023
Q4 		$46.6M Sell
87,744
-50,329
-36% -$24.4M 1.37% 20
2023
Q3 		$69.9M Sell
138,073
-7,017
-5% -$3.74M 2.23% 13
2023
Q2 		$75.7M Sell
145,090
-2,046
-1% -$1.1M 2.21% 14
2023
Q1 		$84.8M Sell
147,136
-1,169
-0.8% -$659K 2.62% 15
2022
Q4 		$81.7M Sell
148,305
-7,918
-5% -$4.2M 2.5% 15
2022
Q3 		$79.2M Sell
156,223
-5,136
-3% -$2.87M 2.47% 16
2022
Q2 		$87.7M Sell
161,359
-4,812
-3% -$2.65M 2.44% 16
2022
Q1 		$98.1M Sell
166,171
-14,715
-8% -$8.45M 2.36% 15
2021
Q4 		$121M Buy
180,886
+3,761
+2% +$2.35M 2.54% 13
2021
Q3 		$101M Sell
177,125
-13,585
-7% -$7.46M 2.5% 14
2021
Q2 		$96.2M Sell
190,710
-39,129
-17% -$18.5M 2.42% 15
2021
Q1 		$105M Buy
229,839
+2,220
+1% +$1.06M 2.89% 12
2020
Q4 		$106M Buy
227,619
+20,370
+10% +$9.55M 3.02% 13
2020
Q3 		$91.5M Buy
207,249
+3,920
+2% +$1.62M 2.69% 14
2020
Q2 		$73.7M Sell
203,329
-16,420
-7% -$5.5M 2.43% 15
2020
Q1 		$62.3M Sell
219,749
-22,215
-9% -$7.01M 2.36% 16
2019
Q4 		$78.6M Buy
241,964
+3,770
+2% +$1.14M 2.52% 16
2019
Q3 		$69.4M Sell
238,194
-11,527
-5% -$3.3M 2.32% 16
2019
Q2 		$73.3M Sell
249,721
-66
-0% -$18.2K 2.42% 16
2019
Q1 		$68.4M Sell
249,787
-9,794
-4% -$2.44M 2.4% 17
2018
Q4 		$58.1M Buy
259,581
+111,304
+75% +$26.1M 2.13% 20
2018
Q3 		$36.2M Buy
148,277
+26,581
+22% +$6.12M 1.19% 29
2018
Q2 		$25.2M Buy
121,696
+59,625
+96% +$12.7M 0.89% 38
2018
Q1 		$12.8M Sell
62,071
-184
-0.3% -$38.6K 0.49% 43
2017
Q4 		$11.8M Sell
62,255
-1,409
-2% -$270K 0.46% 41
2017
Q3 		$12M Buy
63,664
+1,255
+2% +$227K 0.47% 48
2017
Q2 		$10.9M Sell
62,409
-52,699
-46% -$8.85M 0.42% 47
2017
Q1 		$17.7M Sell
115,108
-431,897
-79% -$66M 0.69% 39
2016
Q4 		$77.2M Buy
547,005
+10,152
+2% +$1.5M 3.13% 9
2016
Q3 		$85.4M Buy
536,853
+20,726
+4% +$3.19M 3.33% 12
2016
Q2 		$76.3M Buy
516,127
+82,685
+19% +$12.2M 2.71% 18
2016
Q1 		$61.4M Buy
433,442
+41,003
+10% +$5.5M 2.26% 21
2015
Q4 		$55.7M Sell
392,439
-92,975
-19% -$12.4M 1.96% 24
2015
Q3 		$59.4M Buy
485,414
+242,960
+100% +$31.7M 2.11% 21
2015
Q2 		$31.5M Sell
242,454
-211,877
-47% -$27.6M 1.15% 27
2015
Q1 		$61M Buy
454,331
+201,562
+80% +$26M 2.17% 20
2014
Q4 		$31.7M Sell
252,769
-6,472
-2% -$787K 1.1% 33
2014
Q3 		$31.5M Buy
+259,241
New +$31.5M 1.06% 34

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Chilton Investment Company's TMO Position: Q1 2026 in Review

Chilton Investment Company reduced its Thermo Fisher Scientific (TMO) stake by 4.5% in Q1 2026, selling an estimated $1.18M and leaving 45,954 shares worth $22.6M. The position accounts for 0.53% of the portfolio, ranked #36.

Chilton Investment Company first reported a position in TMO in Q3 2014 and has held it in 47 quarters since. The position peaked at $121M in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Chilton Investment Company held 45,954 shares of Thermo Fisher Scientific worth $22.6M as of Q1 2026.
  • Chilton Investment Company sold 2,170 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.18M.
  • Thermo Fisher Scientific made up 0.53% of Chilton Investment Company's portfolio in Q1 2026, its #36 holding.
  • Chilton Investment Company first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 47 quarters since.
  • Chilton Investment Company's Thermo Fisher Scientific position peaked at $121M in Q4 2021.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Chilton Investment Company's 13F filing for Q1 2026, filed 15 May 2026.